Option Care Health (NASDAQ:OPCH) Updates FY 2025 Earnings Guidance

12 Jan 2026, 23:56 by Teresa Graham · The Cerbat Gem

Option Care Health (NASDAQ:OPCH – Get Free Report) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided earnings per share guidance of 1.720-1.760 for the period, compared to the consensus earnings per share estimate of 1.640. The company issued revenue guidance of $5.6 billion-$5.7 billion, compared to the consensus revenue estimate of $5.6 billion. Option Care Health also updated its FY 2026 guidance to 1.820-1.920 EPS.

Option Care Health Stock Performance

Shares of NASDAQ OPCH traded up $0.26 during trading hours on Monday, hitting $32.06. 1,516,765 shares of the company’s stock were exchanged, compared to its average volume of 1,555,112. The company’s 50-day moving average price is $30.83 and its 200-day moving average price is $29.40. Option Care Health has a 1-year low of $24.24 and a 1-year high of $35.53. The stock has a market capitalization of $5.09 billion, a price-to-earnings ratio of 25.44, a PEG ratio of 1.98 and a beta of 0.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.56 and a quick ratio of 1.05.

Wall Street Analyst Weigh In

OPCH has been the subject of a number of research reports. Wall Street Zen raised shares of Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday. Barrington Research reaffirmed an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a research report on Friday, October 31st. JMP Securities set a $36.00 price objective on Option Care Health in a research report on Friday, October 31st. Citizens Jmp cut their target price on Option Care Health from $38.00 to $36.00 and set a “market outperform” rating for the company in a research note on Friday, October 31st. Finally, Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research report on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $36.27.

Read Our Latest Research Report on OPCH

Insider Buying and Selling at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of the business’s stock in a transaction dated Monday, November 3rd. The shares were acquired at an average price of $25.98 per share, with a total value of $987,240.00. Following the completion of the purchase, the director directly owned 413,390 shares of the company’s stock, valued at $10,739,872.20. The trade was a 10.12% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.64% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Option Care Health

Institutional investors and hedge funds have recently made changes to their positions in the company. Durable Capital Partners LP boosted its position in Option Care Health by 134.2% during the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after acquiring an additional 4,720,988 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its position in Option Care Health by 17.3% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 4,001,307 shares of the company’s stock worth $111,076,000 after buying an additional 590,913 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Option Care Health by 6.6% during the 3rd quarter. Dimensional Fund Advisors LP now owns 3,796,396 shares of the company’s stock worth $105,384,000 after buying an additional 235,413 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of Option Care Health by 3.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,706,671 shares of the company’s stock valued at $55,433,000 after acquiring an additional 55,182 shares in the last quarter. Finally, Bank of America Corp DE grew its holdings in shares of Option Care Health by 1.1% in the 3rd quarter. Bank of America Corp DE now owns 1,705,416 shares of the company’s stock valued at $47,342,000 after acquiring an additional 18,368 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

(Get Free Report)

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.